Please login to the form below
Valeant
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Valeant's Japan sales performance.
Daily Brief: Andrew Witty's replacement on Accelerated Access initiative, Blincyto gains full EU approval and more
Valeant shares tumble after FDA rejection. A rejection by the US regulator for Valeant’s plaque psoriasis treatment. ... Valeant said in a statement that the FDA had not specified any clinical efficacy or safety shortcomings in its Complete Response
UK, Germany back routine use of J&J’s Tremfya
Add in additional IL-17 inhibitors for Eli Lilly and Valeant and the market for biologics for psoriasis is looking increasingly crowded, and a lot will depend on which of the
Daily Brief
Looking to distance itself from toxic past, Valeant to rebrand as Bausch Health. ... Valeant’s years of buccaneering mergers and acquisitions, suspect business practices and allegations of fraud have left it saddled with debt and a pariah-like status
Sun Pharma passes milestone with novel psoriasis drug approval
IL-23-selective follow-up Tremfya (guselkumab) as well as three IL-17 inhibitors - Novartis’ Cosentyx (secukinumab), Eli Lilly’s Taltz (ixekizumab) and Valeant Pharma’s Siliq (brodalumab).
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
-
Consumer Health Account Director
-
Circa £60, 000 Gym and More
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
Senior Account Manager
-
Negotiable
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
-
Account Director
-
Excellent benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Associate Medical Director
-
Highly Competitive
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Senior Systematic Review Analyst - Oxford
-
Negotiable
- Director, Market Access / HEOR - North-West
-
Negotiable
-
Medical Writers
-
Competitive Salary and Benefits
-
Associate Director
-
£75, 000-90, 000
-
Senior Medical Writer
-
Competitive Salary
Subscribe to our email news alerts
- Cell Therapy Systems Market Professional Study and Research Report 2017 – 2027
- Vitreoretinal Surgery Devices Market Is Expected To Generate Huge Profits by 2017-2027
- Hirschsprung Disease Treatment Market Healthy Pace throughout the Forecast during 2017 – 2027
- Wavefront Aberrometers Market is Set to Experience Revolutionary Growth by 2027
- Endoscopy Fluid Management Systems Market Poised to Expand at a Robust Pace Over 2017 – 2027
- Primary Biliary Cholangitis (PBC) Treatment Market Investment Research Report 2017 – 2027
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....
Latest intelligence
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
- Nudge-nudge, think-think
- Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
- Quality in Care Diabetes 2018: the best in innovative diabetes care
- Awards highlight new evidence-based approaches to improving care...
Quick links
Infographics
